Related Experiment Video
Updated: Apr 16, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
4.5K
Beta-blockers use for hypertension in the elderly.
1Hospital Universitario Central de Asturias, C/ Angel MunizToca, 14, 6ºB, 33006 Oviedo, Spain. fiiperva@yahoo.es.
Cardiovascular & Hematological Agents in Medicinal Chemistry
|March 12, 2015
Summary
Beta-blockers are effective for treating hypertension in elderly patients, showing no significant difference compared to other drug classes. Newer vasodilating beta-blockers offer additional benefits for cardiovascular health.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Essential hypertension is common in elderly patients.
- Current guidelines recommend beta-blockers for hypertension management in older adults.
- Comparative efficacy of beta-blockers versus other antihypertensives in the elderly requires ongoing evaluation.
Purpose of the Study:
- To evaluate the efficacy of beta-blockers in treating essential hypertension in elderly patients.
- To compare the blood pressure-lowering effects of beta-blockers with other drug classes in this demographic.
- To highlight the advantages of newer vasodilating beta-blockers.
Main Methods:
- Meta-analyses of clinical trials.
- Review of large-scale clinical trial data.
- Comparative analysis of drug classes for hypertension treatment.
Main Results:
- Beta-blockers demonstrate comparable efficacy to other drug classes in reducing blood pressure in elderly hypertensive patients.
- Newer vasodilating beta-blockers (nebivolol, carvedilol, celiprolol) offer distinct advantages over traditional agents.
- The cardio-protective effects of most beta-blockers are not inferior to other classes, irrespective of age or gender.
Conclusions:
- Beta-blockers remain a suitable and recommended option for managing hypertension in the elderly.
- Vasodilating beta-blockers represent an advancement in hypertension therapy for older individuals.
- The cardiovascular benefits of beta-blockers are well-established and age-independent.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
1.2K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
2.0K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
2.0K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K
01:28Antihypertensive Drugs: Types of β-Blockers
2.0K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
2.0K
01:15Drug Dosing: Geriatric Patients
374
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
374
01:17Antihypertensive Drugs: Action of β1 Blockers
2.3K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.3K